The forecast for Italy's import of antisera and other blood fractions indicates a consistent growth trajectory from 2024 to 2028. Starting in 2024 with a value of $5.7377 billion, the imports are projected to increase steadily each year, reaching $6.3241 billion by 2028. This translates to a year-on-year growth rate of approximately 2.64% from 2024 to 2025, and a similar rate for subsequent years, reflecting a stable demand increase.

Given the absence of data for 2023, the calculated Compound Annual Growth Rate (CAGR) over the five-year forecast period from 2024-2028 is 2.46%, indicating a modest but reliable annual expansion in this sector.

Future trends to watch for include:

Potential advancements and innovations in biotechnology, which could impact demand dynamics.
Changes in healthcare policies affecting the availability and importation of blood-related products.
Market disruptions due to geopolitical factors or pandemics that could alter supply chains.